 RANCHO CUCAMONGA, Calif.--BUSINESS WIRE--PURE Bioscience, Inc. OTCQB: PURE the Company, PURE or we, creator of the patented non-toxic silver dihydrogen citrate SDC antimicrobial, today reported financial results for the fiscal third quarter and nine-month period ended April 30, 2021. Q3: Summary of Results of Operations Net product sales for the fiscal third quarter ended April 30, 2021 decreased 75 to 556,000, compared to 2,221,000 for the fiscal third quarter ended April 30, 